5Vallbohmer D,Kuhn E,Warnecke-Eberz U,et al.Failure in downregulation of intratumoral surviving expression foll-owing neoadjuvant chemoradiation in esophageal cance[J].Pharmacogenomics,2008,9(6):681-690. 被引量:1
6Zemanova M,Petruzelka L,Pazdro A,et al.Prospective nonrandomized study of preoperative concurrent platinum plus 5-fluorouracil-based chemoradiotherapy with or without-paclitaxel in esophageal cancer patients:long-term follow up[J].Dis Esophagus,2010,23(2):160-167. 被引量:1
7Sagar PM,Gauperaa T,Sue-Ling H, et al. An audit of the treatment of cancer of the oesophagus[J]. Gut,1994,35:941-945. 被引量:1
8Daly JM, Karnell LH, Menck HR. National cancer data base report on esophageal carcinoma[J]. Cancer, 1996,78 (8) : 1820-1828. 被引量:1
9Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for lo- calized esophageal eancer[J]. N Engl J Med, 1998,339 (27) : 1979 1984. 被引量:1